Sector
PharmaceuticalsOpen
₹9.75Prev. Close
₹0Turnover(Lac.)
₹7.47Day's High
₹9.8Day's Low
₹9.752 Week's High
₹052 Week's Low
₹0Book Value
₹2.4Face Value
₹2Mkt Cap (₹ Cr.)
81.26P/E
0EPS
0Divi. Yield
013 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
11 Dec 2024
12:00 AM
AGM
Announcement Date: 11 Dec, 2024
5 Jul 2024
12:00 AM
EGM
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 16.58 | 16.58 | 16.58 | 16.58 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 72.83 | 116.73 | 440.69 | 507.88 |
Net Worth | 89.41 | 133.31 | 457.27 | 524.46 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 276.6 | 261.38 | 569.83 | 319.39 |
yoy growth (%) | 5.82 | -54.12 | 78.41 | -25.74 |
Raw materials | -150.3 | -86.4 | -179.93 | -131.54 |
As % of sales | 54.33 | 33.05 | 31.57 | 41.18 |
Employee costs | -31.86 | -34.08 | -42.23 | -23.99 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | -20.74 | 8.85 | 173.38 | 11.34 |
Depreciation | -16.56 | -18.14 | -26.83 | -18.79 |
Tax paid | 1.57 | 1.01 | -47.04 | -3.21 |
Working capital | -97.43 | -74.68 | -7.35 | 108.09 |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 5.82 | -54.12 | 78.41 | -25.74 |
Op profit growth | -57.98 | -69.29 | 193.76 | -19.39 |
EBIT growth | -63.3 | -73.88 | 244.54 | -22.16 |
Net profit growth | -294.28 | -92.19 | 1,454.62 | -57.07 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 116.27 | 149.07 | 187.1 | 237.29 | 861.47 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 116.27 | 149.07 | 187.1 | 237.29 | 861.47 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 4.37 | 9.98 | 0.97 | 1.27 | 9.82 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,702.2 | 95.56 | 4,08,594.75 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,584 | 79.09 | 1,74,634.52 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,572 | 24.56 | 1,26,893.68 | 1,303.13 | 1.02 | 4,501.66 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,622.9 | 64.84 | 1,22,679.27 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,287.4 | 15.58 | 1,07,373.12 | 2,961.2 | 0.62 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & Chief Executive Officer
Santosh Varalwar
Whole-time Director
Subhash Varalwar
Whole-time Director
V Manohar Rao
Independent Director
M Bhagavantha Rao
Whole-time Director
Sandeep Varalwar
Whole Time Director & Chief Financial Officer
S Raghunandan
Independent Director
V Peesapati
Company Secretary
Yugandhar Kopparthi
Additional Director
Aparna Bidarkar
Plot No 78-A,
Kolhar Industrial Area,
Karnataka - 585403
Tel: 91-8482-232045
Website: http://www.vivimedlabs.com
Email: yugandhar.kopparthi@vivimedlabs.com
1-2-285 Domalguda,
Hyderabad - 500 029
Tel: 91-040-27638111/4445
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
Vivimed Labs Limited was originally incorporated on September 22, 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd. On April 21, 1994, the company got converte...
Read More
Reports by Vivimed Labs Ltd
What is the Vivimed Labs Ltd share price today?
What is the Market Cap of Vivimed Labs Ltd?
What is the PE and PB ratio of Vivimed Labs Ltd?
What is the 52 Week High and Low of Vivimed Labs Ltd?
What is the CAGR of Vivimed Labs Ltd?
What is the shareholding pattern of Vivimed Labs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.